Brenntag (FRA:BNR) PT Set at €57.00 by Goldman Sachs Group

Goldman Sachs Group set a €57.00 ($66.28) target price on Brenntag (FRA:BNR) in a report published on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Several other equities research analysts have also weighed in on the company. Deutsche Bank reiterated a hold rating and issued a GBX 1,775 ($23.19) price objective on shares of in a research note on Wednesday, June 26th. Jefferies Financial Group lowered their price objective on Seres Therapeutics from $6.00 to $4.00 and set a hold rating on the stock in a research note on Monday, July 1st. Kepler Capital Markets set a €112.00 ($130.23) price objective on LEG Immobilien and gave the company a buy rating in a research note on Thursday, May 9th. Baader Bank set a €50.00 ($58.14) price objective on Brenntag and gave the company a buy rating in a research note on Wednesday. Finally, JPMorgan Chase & Co. set a €50.00 ($58.14) price objective on Brenntag and gave the company a buy rating in a research note on Tuesday, July 16th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Brenntag currently has a consensus rating of Buy and an average target price of €52.77 ($61.36).

BNR stock opened at €43.60 ($50.70) on Wednesday. Brenntag has a 1-year low of €43.06 ($50.07) and a 1-year high of €56.25 ($65.41). The firm has a 50 day moving average of €43.04.

Brenntag Company Profile

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

See Also: Buy Rating

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.